News
Bayer-Attralus Diagnostic Tracers Deal Expands Imaging Reach
In order to broaden its portfolio in imaging and cardiovascular medicine, Bayer has agreed to purchase two experimental diagnostic imaging agents from Attralus. The...
Business & Industry
UK Clinical Trial Regulatory Reforms Aim to Boost Research
A number of regulatory changes have been released by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to facilitate clinical research in the...
News
The Future of Vertigo Diagnostic and Treatment Options in 2026
Vertigo is an uncomfortable sensation in which you feel as though your body or the world is moving or spinning, even when you are...
Press Releases
Kindeva Announces Leadership Transition to Drive Strategic Growth
Kindeva, a global contract development and manufacturing organization (CDMO) and drug delivery innovator, today announced a series of planned leadership transitions designed to position the...
News
Why Medical Conferences Matter in Modern Healthcare
The physical gathering of healthcare professionals, researchers, and industry leaders remains an indispensable cornerstone of progress. Far from being obsolete, medical conferences serve as...
BioPharma
How APAC Biotech Plans to Turn 2026 Trends into Innovation While Managing Risk?
Asia-Pacific’s biotechnology landscape is not just growing it is transforming. In 2026, the region stands at a unique crossroads where scientific ambition meets real-world...
Business & Industry
Teva, Royalty Pharma $500M Deal to Advance Autoimmune Drug
Teva Pharmaceutical Industries and Royalty Pharma have signed a funding agreement valued at up to $500 million to advance the development of TEV-408, an...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read